View Article

  • A Comprehensive Review on Cancer: Molecular Mechanisms, Risk Factors, Diagnosis, and Advanced Therapeutic Strategies

  • L. N. College of Pharmaceutical Studies Indore

Abstract

Cancer is a multifactorial disease characterized by abnormal cell proliferation, loss of growth control, and the ability to invade surrounding tissues and spread to distant organs. It arises due to genetic mutations, epigenetic alterations, and environmental influences. Despite advancements in medical science, cancer remains a major cause of mortality worldwide. This review provides an in-depth understanding of cancer biology, risk factors, diagnostic approaches, conventional treatments, and emerging therapies such as immunotherapy and gene-based treatments. The study emphasizes the importance of early detection and innovative therapeutic strategies to improve patient outcomes.

Keywords

Cancer, Carcinogenesis, Epidemiology, Chemotherapy, Immunotherapy, Targeted Therapy, Precision Medicine.

Introduction

× Popup Image

Cancer is not a single disease but a collection of disorders involving abnormal and uncontrolled cell growth. Under normal conditions, cell division is tightly regulated by cellular signaling pathways. However, in cancer, these regulatory mechanisms fail, leading to excessive cell proliferation. The transformation of a normal cell into a cancerous cell occurs gradually through multiple stages, including initiation, promotion, and progression. During this process, cells acquire the ability to resist cell death, sustain proliferative signaling, and invade nearby tissues.

2. Molecular Biology of Cancer

Cancer development involves complex molecular changes:

2.1 Genetic Mutations

Mutations in DNA are the primary cause of cancer. These mutations may occur spontaneously or due to exposure to carcinogens. Important gene categories include:

  • Oncogenes: Promote uncontrolled cell growth
  • Tumor suppressor genes: Normally inhibit cell division
  • DNA repair genes: Maintain genetic stability

2.2 Epigenetic Changes

Alterations in gene expression without changes in DNA sequence also contribute to cancer development.

2.3 Angiogenesis

Tumors stimulate new blood vessel formation to ensure a continuous supply of oxygen and nutrients.

2.4 Metastasis

Cancer cells detach from the primary tumor, enter the bloodstream or lymphatic system, and establish secondary tumors in distant organs.

2.5 Evasion of Apoptosis

Cancer cells bypass programmed cell death, allowing them to survive longer than normal cells.

 3. Global Burden of Cancer

Cancer represents a significant global health challenge:

  • Approximately 20 million new cases are diagnosed each year
  • Around 10 million deaths annually
  • Increasing prevalence due to aging population and lifestyle changes

Most Common Types:

  • Lung cancer
  • Breast cancer
  • Colorectal cancer
  • Prostate cancer

Developing countries are experiencing a rapid increase in cancer incidence due to urbanization and environmental factors.

4. Risk Factors of Cancer

Cancer risk factors can be classified into different categories:

4.1 Lifestyle Factors

  • Tobacco use (leading cause of cancer-related deaths)
  • Alcohol consumption
  • Poor diet and obesity
  • Physical inactivity

4.2 Environmental Factors

  • Air pollution
  • Exposure to radiation
  • Industrial chemicals

4.3 Biological Factors

  • Viral infections (HPV, Hepatitis viruses)
  • Hormonal imbalances
  • Genetic predisposition

5. Diagnosis of Cancer

Early diagnosis is crucial for effective treatment:

5.1 Imaging Techniques

  • X-ray
  • CT scan
  • MRI
  • PET scan

5.2 Biopsy

Removal of tissue sample for microscopic examination.

5.3 Molecular Testing

Identification of genetic mutations and biomarkers.

5.4 Blood Tests

Tumor markers help in detection and monitoring.

6. Conventional Treatment Approaches

6.1 Chemotherapy

Uses drugs to destroy rapidly dividing cancer cells but may also affect normal cells.

6.2 Radiotherapy

High-energy radiation damages cancer cell DNA.

6.3 Surgery

Used to remove localized tumors.

6.4 Targeted Therapy

Acts on specific molecular targets involved in cancer growth, minimizing damage to normal cells.

7. Emerging and Advanced Therapies

7.1 Immunotherapy

 
 

Enhances the immune system’s ability to recognize and destroy cancer cells.

7.2 CAR-T Cell Therapy

Patient’s T-cells are genetically modified to specifically target cancer cells.

7.3 Gene Therapy

Involves correcting defective genes responsible for cancer.

7.4 mRNA Vaccines

Train the immune system to identify tumor-specific proteins.

7.5 Artificial Intelligence

Used for early detection, diagnosis, and personalized treatment planning.

8. Challenges in Cancer Management

  • Development of drug resistance
  • Severe side effects of treatments
  • Late-stage diagnosis
  • High cost of advanced therapies
  • Limited accessibility in developing regions

9. Future Perspectives

Future cancer research is focused on:

  • Personalized and precision medicine
  • Nanotechnology-based drug delivery systems
  • Early detection using biomarkers
  • Combination therapies for better outcomes

CONCLUSION

Cancer continues to be a major global health concern, but advancements in research and technology have significantly improved diagnosis and treatment. A deeper understanding of molecular mechanisms and the development of innovative therapies offer hope for better management and potential cures. Early detection, lifestyle modifications, and continued scientific research are essential to reduce the global burden of cancer.

REFERENCES

  1. World Health Organization. (2024). Cancer report.
  2. National Cancer Institute. (2023). Overview of cancer biology.
  3. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer. Cell, 144(5), 646–674.
  4. Siegel, R. L., Miller, K. D., & Jemal, A. (2023). Cancer statistics. CA: A Cancer Journal for Clinicians.
  5. June, C. H., et al. (2018). CAR T-cell therapy. Science, 359(6382).
  6. Sharma, P., & Allison, J. P. (2015). Immune checkpoint therapy. Science.
  7. International Agency for Research on Cancer. (2023). World cancer report 2023.
  8. American Cancer Society. (2024). Cancer facts & figures 2024.
  9. National Cancer Institute. (2023). Targeted cancer therapies.
  10. Vogelstein Bert, & Kinzler Kenneth W. (2004). Cancer genes and pathways. Science, 304(5670), 554–558.
  11. Hanahan Douglas, & Weinberg Robert A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70.
  12. Allison James P. (2015). Immune checkpoint blockade in cancer therapy. Science, 348(6230), 56–61.
  13. June Carl H, et al. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382).
  14. CRISPR-Cas9 research overview. (2020). Nature Reviews Drug Discovery.
  15. U.S. Food and Drug Administration. (2023). Approved cancer immunotherapies.

Reference

  1. World Health Organization. (2024). Cancer report.
  2. National Cancer Institute. (2023). Overview of cancer biology.
  3. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer. Cell, 144(5), 646–674.
  4. Siegel, R. L., Miller, K. D., & Jemal, A. (2023). Cancer statistics. CA: A Cancer Journal for Clinicians.
  5. June, C. H., et al. (2018). CAR T-cell therapy. Science, 359(6382).
  6. Sharma, P., & Allison, J. P. (2015). Immune checkpoint therapy. Science.
  7. International Agency for Research on Cancer. (2023). World cancer report 2023.
  8. American Cancer Society. (2024). Cancer facts & figures 2024.
  9. National Cancer Institute. (2023). Targeted cancer therapies.
  10. Vogelstein Bert, & Kinzler Kenneth W. (2004). Cancer genes and pathways. Science, 304(5670), 554–558.
  11. Hanahan Douglas, & Weinberg Robert A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70.
  12. Allison James P. (2015). Immune checkpoint blockade in cancer therapy. Science, 348(6230), 56–61.
  13. June Carl H, et al. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382).
  14. CRISPR-Cas9 research overview. (2020). Nature Reviews Drug Discovery.
  15. U.S. Food and Drug Administration. (2023). Approved cancer immunotherapies.

Photo
Disha Songara
Corresponding author

L. N. College of Pharmaceutical Studies Indore

Photo
Ajay Choudhary
Co-author

L. N. College of Pharmaceutical Studies Indore

Disha Songara*, Ajay Choudhary, A Comprehensive Review on Cancer: Molecular Mechanisms, Risk Factors, Diagnosis, and Advanced Therapeutic Strategies, Int. J. Med. Pharm. Sci., 2026, 2 (5), 216-226. https://doi.org/10.5281/zenodo.20051630

More related articles
Chemoresistance In Cancer and Novel Strategies to ...
Padige Srivarsha, Shirley Angelina Kothur, Perne Venkata Adithya...
A Review on Targeted Drug Delivery in Cancer Thera...
Gayatri Khanderao, Shivaji Mohrut, Samadhan Magar, Nitin Lodhe, N...
Design and Development of Nano Lipid Carrier Based...
Momin Llsa M. A., Dhaynendra Singh Baghel...
The Invisible Saboteur: A Molecular Review of Dimethylmercury-Induced Neurotoxic...
Arnab Roy, Shivam Kashyap, Sha Chandankumar Manojkumar, Satyam Nath, Satish Kumar, Rohit Kumar Sharm...
Measurement of Quality of Life and Associated Risk Factors in Patients with Isch...
Shamini J., Soumya R. V., Prasobh G. R., Nithin Manohar R., Mahitha, Aswathy K. S., Abisek...
Related Articles
Gastric Adenocarcinoma: The Use of Animal Models to Research Risk Factors, Preve...
Jubershaha Salimshaha Fakir, Vitthal Kundgir, Madhuri Davange, Harshali Khairnar , Dipti Chavan, Abd...
Chemoresistance In Cancer and Novel Strategies to Overcome Therapeutic Resistanc...
Padige Srivarsha, Shirley Angelina Kothur, Perne Venkata Adithya...
More related articles
Chemoresistance In Cancer and Novel Strategies to Overcome Therapeutic Resistanc...
Padige Srivarsha, Shirley Angelina Kothur, Perne Venkata Adithya...
A Review on Targeted Drug Delivery in Cancer Therapy: Advances, Challenges, and ...
Gayatri Khanderao, Shivaji Mohrut, Samadhan Magar, Nitin Lodhe, Nilesh Sawadadkar, Nandu Kayande, Ar...
Chemoresistance In Cancer and Novel Strategies to Overcome Therapeutic Resistanc...
Padige Srivarsha, Shirley Angelina Kothur, Perne Venkata Adithya...
A Review on Targeted Drug Delivery in Cancer Therapy: Advances, Challenges, and ...
Gayatri Khanderao, Shivaji Mohrut, Samadhan Magar, Nitin Lodhe, Nilesh Sawadadkar, Nandu Kayande, Ar...